Trial Profile
A Phase I Trial of Regorafenib and Cetuximab in Patients With Solid tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jan 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Regorafenib (Primary)
- Indications Colorectal cancer; Solid tumours
- Focus Adverse reactions
- 08 Jan 2016 New trial record
- 09 Nov 2015 Results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2015